Method for the treatment of increased urinary urgency or urinary incontinence comprising administering (+)-tramadol, O-demethyltramadol, (+)-O-demethyltramadol, O-desmethyl-N-mono-desmethyltramadol, or (+)-O-desmethyl-N-mono-desmethyltramadol, as free bases and/or in the form of physiologically compatible salts, are disclosed.
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a continuation of international patent application no. PCT/EP00/09420, filed Sep. 20, 2000, designating the United States of America, the entire disclosure of which is incorporated herein by reference. Priority is claimed based on Federal Republic of Germany patent application nos. 199 47 747.7, filed Oct. 5, 1999 and 200 02 943.6, filed Feb. 21, 2000.
Priority Data
Oct 05, 1999 [DE] 199 47 747 Jun 21, 2000 [DE] 200 02 943
Substituted 1-aminobutane-3-ol compounds, methods for producing them, pharmaceutical compounds containing them, and the use of substituted 1-aminobutane-3-ol compounds for producing pharmaceutical compounds.
A method for treating increased uninary urgency or urinary incontinence, comprising administering an effective amount of a compound corresponding to formula I ##STR00001## It has been surprisingly discovered that the methods of the present invention are effective for treating increased urinary urgency or urinary incontinence. Also disclosed are methods of treatment using related pharmaceutical compositions.
